The spirit of our founders: The values and mindsets that created Novo Nordisk a century ago

(24:15)

Novo Nordisk and Eli Lilly will dominate the obesity drug market long-term, says Mizuho's Jared Holz

(2:53)

Novo Nordisk Selloff Is an Overreaction, Barclays' Field Says

(4:35)

Novo Nordisk: Why the stock of the Danish pharmaceutical giant is plunging

(4:8)

CEO DIALOGUE #35 - Lars Fruergaard Jørgensen, Novo Nordisk

(49:8)

Novo Nordisk (Ozempic)

(3:45:26)

Novo Nordisk is 'losing its pep' in GLP-1 race: BMO analyst

(6:22)

How Ozempic And Wegovy Accidentally Made Novo Nordisk A $400B Company

(19:20)

How a new Denmark tariff could impact Novo Nordisk

(2:49)

How to use NovoPen 4

(6:46)

NBC News Exclusive: Ozempic and Wegovy Novo Nordisk CEO speaks out on high prices, drug shortages

(4:29)

How Novo Nordisk built an empire selling diabetes and weight-loss drugs

(2:16)

Novo Nordisk CEO defends high price off Ozempic and Wegovy

(5:)

Novo Nordisk plunges after obesity drug trial disappoints | REUTERS

(1:31)

BMO’s Evan David Seigerman cuts Novo Nordisk price target after Cagrisema data disappoints

(4:1econd)

Novo Nordisk's weight loss drug Wegovy available in France from Tuesday • FRANCE 24 English

(1:48)

Join us in Novo Nordisk Manufacturing

(1:29)

Novo Nordisk stock plunges on obesity shot trial results

(3:25)

Novo Nordisk CEO Lars Jorgensen testifies before Senate on weight loss drugs pricing — 9/24/24

(2:15:10)